Pharmaceuticals Weekly: Weekly Rx Update

Research evidence excerpt

Pharmaceuticals Weekly: Weekly Rx Update

J P M O R G A N North America Equity Research

19 June 2026

Pharmaceuticals Weekly

Weekly Rx Update

Below, we highlight the latest IQVIA data for the week ended 6/12/2026. Pharmaceuticals — Major &

Specialty

Please note there has been a data capture issue (beginning the week ending 4/24) Chris Schott, CFA AC

for Zepbound that leads to an understatement for vials & Kwikpen. Additionally, (1-212) 622-5676

there is a data capture issue (starting the week ending 5/22) for Foundayo. christopher.t.schott@jpmorgan.com

Ethan Brown

Figure 1: Select Key Product Weekly Scripts (1-212) 622-4928

ethan.brown@jpmchase.com

wTRx wNRx y/y

Drug Company 5/22 5/29 6/5 6/12 5/22 5/29 6/5 6/12 TRx (%) Hardik Parikh, CFA

Mounjaro LLY 796,781 756,666 830,657 804,502 388,894 353,711 397,079 384,598 40%

Zepbound LLY 659,022 610,787 667,376 649,813 360,235 328,313 363,970 353,405 59% (1 212) 622-2875

Foundayo LLY 16,011 16,982 19,879 21,648 14,584 15,607 18,278 19,895 NA hardik.k.parikh@jpmorgan.com

Skyrizi ABBV 27,829 22,225 27,882 26,351 12,462 9,672 12,509 11,730 25%

Rinvoq ABBV 34,293 27,470 32,110 31,911 10,814 8,038 10,070 9,322 24%

Camzyos BMY 2,313 2,113 2,490 2,366 776 656 763 723 37% Ekaterina V Knyazkova, CFA

Cobenfy BMY 3,348 2,898 3,432 3,203 2,118 1,798 2,180 2,029 76%

Dupixent REGN 108,358 97,154 105,298 107,812 29,432 23,966 26,902 27,090 19% (1-212) 622-9576

Tremfya J&J 18,579 15,566 18,542 18,480 7,283 5,905 7,109 7,125 74% ekaterina.v.knyazkova@jpmchase.com

Icotyde JNJ 334 231 383 484 249 149 258 318 NA

Caplyta JNJ 22,709 21,520 23,492 23,189 14,298 13,352 14,830 14,637 71% Taylor Hanley

Yeztugo Injectable GILD 1,021 725 981 980 900 617 859 843 N/A

Journvax VRTX 20,902 18,411 22,101 22,432 18,785 16,376 19,896 20,271 323% (1-212) 622-0790